Renova Therapeutics | Finanzwire

Basculer en Français

9629	Companies
191463	Keywords
122919	Articles
102033	Press releases

Home
Companies
Renova Therapeutics

BRIEF

published on 06/12/2024 at 15:05, 1 year 6 months ago

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions

Diabetes Clinical Trials Gene Therapy Renova Therapeutics Heart Failure
PRESS RELEASE

published on 06/12/2024 at 15:00, 1 year 6 months ago

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions
Renova Therapeutics announces exploration of new therapeutic opportunities expanding gene therapy use for diabetes and heart failure. Clinical trials and preclinical studies show promising results

Diabetes Clinical Trials Gene Therapy Renova Therapeutics Heart Failure
BRIEF

published on 05/09/2024 at 03:05, 1 year 8 months ago

Renova Therapeutics Prioritizes Gene Therapy Development for Heart Failure and Type 2 Diabetes

Clinical Trials Gene Therapy Renova Therapeutics Heart Failure Treatment Type 2 Diabetes Treatment
PRESS RELEASE

published on 05/09/2024 at 03:00, 1 year 8 months ago

Renova Therapeutics Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus
Renova Therapeutics prioritizes two primary regulatory pathways for launching pivotal human trials of gene therapies to treat heart failure and type 2 diabetes mellitus

Clinical Trials Gene Therapy Renova Therapeutics Heart Failure Type 2 Diabetes Mellitus

Accesswire

Published on 01/10/2026 at 05:10, 1 day 21 hours ago

Sekur Private Data Ltd. Announces Non-Brokered Private Placement
Published on 01/10/2026 at 00:45, 2 days 1 hour ago

Digi Power X Announces Entry into Settlement Agreement
Published on 01/09/2026 at 23:30, 2 days 3 hours ago

Sun Peak Metals Grants Stock Options
Published on 01/09/2026 at 23:30, 2 days 3 hours ago

Matador Technologies Announces Grant of Restricted Share Units to Management Team
Published on 01/09/2026 at 23:10, 2 days 3 hours ago

Usha Resources and Totec Resources Provide Supplemental Disclosure for Qualifying Transaction

View all ACCESSWIRE

EQS Group

Published on 01/12/2026 at 00:10, 2 hours 29 minutes ago

EQS-Adhoc: Northern Data Announces Expiry of Option to Sell Corpus Christi Site to Global Infrastructure Asset Management Firm
Published on 01/11/2026 at 22:20, 4 hours 19 minutes ago

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Published on 01/10/2026 at 21:25, 1 day 5 hours ago

CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh
Published on 01/10/2026 at 13:05, 1 day 13 hours ago

SeaVerse Launches World's First AI Native Platform, "All in AI Native" Leads the Forward-Looking Revolution in AI Creation
Published on 01/09/2026 at 21:55, 2 days 4 hours ago

Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)

Les Echos

Published on 01/09/2026 at 18:30, 2 days 8 hours ago

H2 2025 half yearly report on the liquidity agreement signed with the Gilbert Dupont brokerage firm
Published on 01/09/2026 at 17:45, 2 days 8 hours ago

January 2026
Published on 01/09/2026 at 17:45, 2 days 8 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 01/09/2026 at 17:42, 2 days 8 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 December 2025
Published on 01/08/2026 at 21:00, 3 days 5 hours ago

Biannual report on SEB S.A.’S liquidity agreement

View all LES ECHOS COMFI WIRE